Strategy for Discontinuation of Anxiolytics in Multidisciplinary Approach-Reference-Cited by-同舟云学术

Strategy for Discontinuation of Anxiolytics in Multidisciplinary Approach

Published:2023-11-30 Issue:1 Volume:15 Page:20-30
ISSN:2188-7578
Container-title:Anxiety Disorder Research
language:en
Short-container-title:Anxiety Disord Res

Author:

Takaesu Yoshikazu¹,Yamada Hisashi²,Ie Kenya³⁴,Kurosawa Masahiro⁵,Aoki Yumi⁶,Inada Ken⁷

Affiliation:

1. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus

2. Department of Neuropsychiatry, Hyogo Medical University

3. Department of General Internal Medicine, St. Marianna University School of Medicine

4. Department of General Internal Medicine, Kawasaki Municipal Tama Hospital

5. Showa University Karasuyama Hospital Pharmacy

6. Psychiatric and Mental Health Nursing, Graduate School of Nursing Science, St. Luke’s International University

7. Department of Psychiatry, Kitasato University School of Medicine

Publisher

Japanese Society of Anxiety Disorders

Link

https://www.jstage.jst.go.jp/article/jsad/15/1/15_20/_pdf

Reference23 articles.

1. American Geriatrics Society (2019). Beers Criteria Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. Epub 2019 Jan 29.

2. Aoki, Y., Takaesu, Y., Inada, K., et al. (2023). Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic. Front Psychiatry, 14, 1083568.

3. Aoki, Y., Takaesu, Y., Inoue, M., et al. (2019). Seven-day shared decision making for outpatients with first episode of mood disorders among university students: a randomized controlled trial. Psychiatry Res, 281, 112531.

4. Aoki, Y., Yaju, Y., Utsumi, T., et al. (2022). Shared decision-making interventions for people with mental health conditions. Cochrane Database Syst Rev, 11(11), CD007297.

5. Asakura, S., Yoshinaga, N., Yamada, H., et al. (2023). Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: clinical practice guideline for social anxiety disorder. Neuropsychopharmacol Rep, 43(3), 288–309.